(Q42515299)

1 November 2017

Enzymatic assay for quantitative analysis of (D)-2-hydroxyglutarate (English)

1 reference

1 November 2017

6

1 reference

1 November 2017

10

Andreas von Deimling

1 reference

1 November 2017

Christel Herold-Mende

4

object named as

Christel Herold-Mende

1 reference

1 November 2017

Jörg Balss

1

1 reference

1 November 2017

Stefan Pusch

2

1 reference

1 November 2017

Ann-Christin Beck

3

1 reference

1 November 2017

Alwin Krämer

5

1 reference

1 November 2017

Wolfgang Buckel

7

1 reference

1 November 2017

Claus-Dieter Langhans

8

1 reference

1 November 2017

Jürgen G Okun

9

1 reference

1 November 2017

2 November 2012

1 reference

1 November 2017

Acta Neuropathologica

1 reference

1 November 2017

124

1 reference

1 November 2017

6

1 reference

1 November 2017

883-891

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-012-1060-y

1 November 2017

0 references

cites work

IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

The reversible dehydration of (R)-2-hydroxyglutarate to (E)-glutaconate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Gas chromatographic and mass spectrometric studies on urinary organic acids in a patient with congenital lactic acidosis due to pyruvate decarboxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

IDH2 mutations in patients with D-2-hydroxyglutaric aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Studies of urinary organic acid profiles of a patient with dihydrolipoyl dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Cancer-associated isocitrate dehydrogenase mutations inactivate NADPH-dependent reductive carboxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Detection of 2-hydroxyglutarate in formalin-fixed paraffin-embedded glioma specimens by gas chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-1060-Y

10.1007/S00401-012-1060-Y

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bwh7usvw7rhz5f3zlbak7b72bm

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_bwh7usvw7rhz5f3zlbak7b72bm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bwh7usvw7rhz5f3zlbak7b72bm

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/bwh7usvw7rhz5f3zlbak7b72bm